RSS

CLNN Clene Inc.

Mod: Add me as mod
Last Post: 09/26/25
Followers: 0
Posts Today: 0
Views Today: 34

CLNN Stock Quote & Tools

Company Profile Buy Rating Time & Sales News Filings Financials

CLNN Stock Message Board Discussion

  1. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) Reveals Important Findings From HEALEY ALS Platform Trial -

  2. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Announces Participation at Upcoming H.C.

  3. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Presents New Preliminary Data Demonstrating

  4. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Presents Extended Survival Data to Support

  5. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) CEO and CFO Present Corporate Updates and Future Plans at 72nd

  6. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) to Present at Emerging Growth Conference

  7. NetworkNewsWire

    Delays in Diagnosing MS Highlight Need for More Awareness, Research A new report has

  8. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) to Present at Emerging Growth Conference

  9. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) Announces Updates on ACT-EAP for CNM-Au8(R) Compassionate Use -

  10. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Issues Update on NIH-Funded Program for CNM-Au8

  11. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) Participates in Three Investor Conferences During May 2024, Promoting

  12. NetworkNewsWire

    Study Identifies Genetic Link Between Parkinsons, Inflammatory Bowel Disease

  13. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Looking to Transform Healthcare for Individuals

  14. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) Announces Key Operational Highlights as part of First Quarter 2024

  15. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Announces Participation Schedule for Upcoming May

  16. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Releases Q1 2024 Financial Numbers, Operation

  17. NetworkNewsWire

    Study Suggests Metabolism Issues After Spinal-Cord Injury Result from Disturbed Neuronal

  18. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) Presents Findings on Phase 2 VISIONARY-MS LTE at American Academy of

  19. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Spotlighted in a Recent From Lab to Launch

  20. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) Continues Development of Lead Drug Candidate CNM Au8(R) for

  21. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Announces Study Results for CNM-Au8 as Multiple

  22. NetworkNewsWire

    Study Identifies Three Distinct Subtypes of Multiple Sclerosis Multiple sclerosis (MS) is

  23. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Looking to Advance Discussions for Accelerated

  24. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) has Emerged as a Leader in the Neurodegenerative Field Utilizing a

  25. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) Announces Publication of Protein Corona Composition of Gold

  26. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) Announces Operational Highlights for Lead Therapeutic Candidate for

  27. NetworkNewsWire

    New Study Leverages Real-World Data to Assess Differences in Parkinsons Progression

  28. NetworkNewsWire

    NetworkNewsBreaks Clene Inc.s (NASDAQ: CLNN) Work in Nanotechnology Highlighted in First

  29. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Announces Publication of Peer-Reviewed Research

  30. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Announces FY 2023 Results, Recent Operating

  31. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Announces Participation at Upcoming 36th Annual

  32. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN), Subsidiary Report Positive Clinical Results of

  33. NetworkNewsWire

    NetworkNewsBreaks Clene Inc.s (NASDAQ: CLNN) CNM-Au8 Aiming to Address Neurodegenerative

  34. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Announces Statistically Significant Results from

  35. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Eyes Rarely Seen Clinically Significant

  36. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) Revolutionizes Approach to Restore Neuronal Health in

  37. NetworkNewsWire

    New MRI Procedure Eases Multiple Sclerosis Diagnosis Researchers from ETH Zurich have

  38. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) Reports Unprecedented, Statistically Significant Long-Term Clinical

  39. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) CEO Discusses MS Trial Results During Latest

  40. NetworkNewsWire

    NetworkNewsBreaks Clene Inc.s (NASDAQ: CLNN) CNM-Au8 Produces Significant and Very

  41. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) Unites Physics, Chemistry, Material Science, and Biology to Address

  42. NetworkNewsWire

    Researchers Propose New Way to Classify Parkinsons Disease A multinational team of

  43. NetworkNewsWire

    Clene Inc. (NASDAQ: CLNN) VISIONARY-MS Trial Data May Support CNM-Au8(R) as Long-Sought-After

  44. NetworkNewsWire

    Ancient DNA Suggests Origins of Multiple Sclerosis in EU A massive cache of ancient

  45. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Announces Significant Positive Results from LTE

  46. NetworkNewsWire

    New Study Highlights Role of Mitochondria in Connecting Cancer to Dietary Fat A research

  47. NetworkNewsWire

    Clene Inc.s (NASDAQ: CLNN) Phase 2 REPAIR-PD and REPAIR-MD Trials Indicate CNM-Au8(R)s

  48. NetworkNewsWire

    Finnish Study Suggests Exercise Plays Smaller Role in Longevity Common knowledge coupled

  49. NetworkNewsWire

    NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN) Announces New Data from HEALEY ALS Platform Trial,

  50. NetworkNewsWire

    How Clene Inc. (NASDAQ: CLNN) CNM-Au8(R) Takes Advantage of Gold Nanocrystals to Target